Clinical Trials Logo

Clinical Trial Summary

First-In-Man Study on the ACURATE TF™ Transfemoral Aortic Bioprosthesis Implantation in Patients with Severe Aortic Stenosis to collect human feasibility data pertaining to the safety and performance of the device.


Clinical Trial Description

A single arm, prospective, multicenter, non-randomized, open trial, up to 5 Years follow-up with the Symetis ACURATE TF™ Transfemoral Aortic Bioprosthesis for minimal invasive implantation via transfemoral access to treat patients with severe aortic stenosis where conventional aortic valve replacement (AVR) via open heart surgery is considered to be associated with high risk. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03752996
Study type Interventional
Source Boston Scientific Corporation
Contact
Status Completed
Phase N/A
Start date May 9, 2012
Completion date March 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT03567278 - Feasibility Trial on ACURATE™ Transapical Implantation in Patients With Severe Symptomatic Aortic Stenosis (2009-01) N/A
Recruiting NCT03998631 - Comparison of Carbon Dioxide and Saline Flush to Saline Flush in TEVAR and TAVI Procedures to Reduce Cerebral Ischemia Phase 1
Completed NCT04755426 - Understanding Patient Goals and Preferences to Facilitate Shared Decision Making for Symptomatic Aortic Stenosis
Recruiting NCT04694859 - Romanian National Registry of Outcomes After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis - RO-TAVI
Active, not recruiting NCT04061213 - ATTR Amyloidosis in Elderly Patients With Aortic Stenosis